Basic information Safety Supplier Related
ChemicalBook >  Product Catalog >  Biochemical Engineering >  Amino Acids and Derivatives >  Glutamic acid derivatives >  tert-butyl 5-oxo-L-prolinate

tert-butyl 5-oxo-L-prolinate

Basic information Safety Supplier Related

tert-butyl 5-oxo-L-prolinate Basic information

Product Name:
tert-butyl 5-oxo-L-prolinate
Synonyms:
  • L-PyroglutaMic acid ter-butyl ester
  • L-Pyr-Otbu
  • L-Proline,5-oxo-, 1,1-diMethylethyl ester
  • tert-butyl (2S)-5-oxopyrrolidine-2-carboxylate
  • tert-Butyl L-PyroglutaMate
  • (S)-tert-Butyl 5-oxopyrrolidine-2-carboxylate
  • 2-Methyl-2-propanyl 5-oxo-L-prolinate
  • tert-Butyl (S)-5-oxo-2-pyrrolidinecarboxylate
CAS:
35418-16-7
MF:
C9H15NO3
MW:
185.22
EINECS:
252-555-5
Mol File:
35418-16-7.mol
More
Less

tert-butyl 5-oxo-L-prolinate Chemical Properties

Melting point:
102.0 to 108.0 °C
Boiling point:
319.2±35.0 °C(Predicted)
Density 
1.099±0.06 g/cm3(Predicted)
storage temp. 
Sealed in dry,Room Temperature
solubility 
soluble in Methanol
pka
14.65±0.40(Predicted)
form 
Powder
color 
White
BRN 
3590226
More
Less

Safety Information

Hazard Codes 
Xi
Risk Statements 
36/38
Safety Statements 
26
WGK Germany 
3
HS Code 
29339900
More
Less

tert-butyl 5-oxo-L-prolinate Usage And Synthesis

Uses

tert-Butyl (S)-2-pyrrolidone-5-carboxylate can be used:

  • As a starting material/synthon in the synthesis of angiotensin-converting enzyme inhibitors.
  • In the synthesis of phenanthroindolizidine alkaloids named (+)-tylophorine and antofine.
  • As a starting material in the synthesis of radioligands [18F]IUR-1602 and [18F]IUR-1601, applicable for imaging of P2X7R, a therapeutic target for neuroinflammation.

Synthesis

540-88-5

98-79-3

35418-16-7

[0492] L-Pyroglutamic acid (5.0 g, 38.73 mmol) was dissolved in tert-butyl acetate (65 mL, 0.48 mol) under nitrogen protection, followed by the slow addition of 70% aqueous perchloric acid (1.25 mL). The reaction mixture was placed in a 250 mL round bottom flask and stirred for 18 hours at room temperature. Upon completion of the reaction, the mixture was carefully poured into saturated aqueous sodium bicarbonate solution to neutralize the excess acid. The aqueous phase was extracted with ethyl acetate (200 mL × 2), and the organic phases were combined and dried over anhydrous sodium sulfate. The organic phase was concentrated under reduced pressure and the residue was recrystallized from a solvent mixture of hexane/ether (10:1). The resulting white solid was collected by filtration and dried to give the title compound (S)-tert-butyl 5-oxopyrrolidine-2-carboxylate S2 (5 g, 70% yield).

References

[1] Synthetic Communications, 2005, vol. 35, # 8, p. 1129 - 1134
[2] European Journal of Organic Chemistry, 2018, vol. 2018, # 4, p. 455 - 460
[3] Organic letters, 2002, vol. 4, # 7, p. 1139 - 1142
[4] Patent: WO2010/45580, 2010, A1. Location in patent: Page/Page column 90
[5] Journal of Medicinal Chemistry, 2012, vol. 55, # 3, p. 1368 - 1381

tert-butyl 5-oxo-L-prolinateSupplier

J & K SCIENTIFIC LTD.
Tel
18210857532; 18210857532
Email
jkinfo@jkchemical.com
PharmaBlock Sciences (Nanjing),Inc.
Tel
025-86918202 4000255188
Email
sales@pharmablock.com
Meryer (Shanghai) Chemical Technology Co., Ltd.
Tel
4006356688 18621169109
Email
market03@meryer.com
Sichuan Tongsheng Amino acids Co.,Ltd.
Tel
0838-2274206 13908101207
Email
sales@biots.cn
TCI (Shanghai) Development Co., Ltd.
Tel
021-67121386
Email
Sales-CN@TCIchemicals.com